The global hemoglobin monitor market is set to experience robust growth, with a projected compound annual growth rate (CAGR) of 7.8% from 2022 to 2032. The market value is expected to increase from ...
The hemoglobin A1C test is a useful tool to help monitor glucose control or diagnose diabetes, but it’s not foolproof. Certain health conditions or medications may interfere with the test ...
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that enrollment is complete for ...